| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/01/2002 | WO2002059318A1 A humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof |
| 08/01/2002 | WO2002059312A2 Cell adhesion proteins |
| 08/01/2002 | WO2002059311A2 Colon cancer marker |
| 08/01/2002 | WO2002059310A2 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | WO2002059308A2 Method of diagnosing and treating cartilage disorders |
| 08/01/2002 | WO2002059299A2 Expression cloning method |
| 08/01/2002 | WO2002059295A1 Novel serine protease mp493 |
| 08/01/2002 | WO2002059291A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | WO2002059286A2 Adenylate cyclases |
| 08/01/2002 | WO2002059283A2 Nucleic acid modification enzymes |
| 08/01/2002 | WO2002059282A2 Adipocyte complement related protein zacrp13 |
| 08/01/2002 | WO2002059280A2 Chronic lymphocytic leukemia cell line and its use for producing an antibody |
| 08/01/2002 | WO2002059267A2 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | WO2002059264A2 Specific human antibodies for selective cancer therapy |
| 08/01/2002 | WO2002059258A2 Chimeric proteins for prevention and treatment of hiv infection |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059155A2 Modulation of calcium channel activity |
| 08/01/2002 | WO2002059154A2 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
| 08/01/2002 | WO2002059153A2 Anticoagulants and their uses |
| 08/01/2002 | WO2002059149A2 Pro-apoptotic proteins and dna molecules encoding them |
| 08/01/2002 | WO2002059148A2 A method for identification, isolation and production of antigens to a specific pathogen |
| 08/01/2002 | WO2002058728A2 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 08/01/2002 | WO2002058719A1 Methods and compositions using cap43 proteins and nucleic acids to diagnose and treat cancer and other disorders |
| 08/01/2002 | WO2002058714A2 Methods and agents modulating upa/upar activity |
| 08/01/2002 | WO2002058635A2 Nicotine immunogens and antibodies and uses thereof |
| 08/01/2002 | WO2002058628A2 Immunotherapeutic methods for extracorporeal modulation of cd36 and its ligands |
| 08/01/2002 | WO2002040048A3 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis |
| 08/01/2002 | WO2002036761A9 Compositions and methods for the diagnosis of cancer |
| 08/01/2002 | WO2002030461A3 Methods for treating disorders of the female reproductive system |
| 08/01/2002 | WO2002022166A3 Tweak receptor agonists as anti-angiogenic agents |
| 08/01/2002 | WO2002020614A3 Endoglin-specific polypeptide, production and use thereof |
| 08/01/2002 | WO2002016437A3 Rhabdovirus-based vectors to express high levels of functional human antibodies |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same |
| 08/01/2002 | WO2001090190A3 Single-domain antigen-binding antibody fragments derived from llama antibodies |
| 08/01/2002 | WO2001083527A3 Glucagon antagonists |
| 08/01/2002 | WO2001080633A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/01/2002 | WO2001075110A3 Mucin-1 specific binding members and methods of use thereof |
| 08/01/2002 | WO2001072836A3 G-protein coupled receptors |
| 08/01/2002 | WO2001070955A3 Identification of essential genes in prokaryotes |
| 08/01/2002 | WO2001029072A9 P15paf cell cycle proteins associated with pcna, compositions and methods of use |
| 08/01/2002 | WO2001026672A9 Induction of a strong immune response to a self-tumor associated antigen |
| 08/01/2002 | WO2000077040A9 Human intracellular signaling molecules |
| 08/01/2002 | US20020104113 Nav2 channel gene-deficient non-human animals |
| 08/01/2002 | US20020103360 Novel protein related to melanoma-inhibiting protein and uses thereof |
| 08/01/2002 | US20020103358 Nucleotide sequences coding preferential polypeptide for use in tumor therapy |
| 08/01/2002 | US20020103345 Bispecific immunoglobulin-like antigen binding proteins and method of production |
| 08/01/2002 | US20020103343 Antigen-based heteropolymers and method for treating autoimmune diseases using the same |
| 08/01/2002 | US20020103340 Rab proteins |
| 08/01/2002 | US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 08/01/2002 | US20020103212 Pharmaceutical compositions containing anti-fas antibody |
| 08/01/2002 | US20020103165 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 08/01/2002 | US20020103151 Methods and compositions for immunomodulation |
| 08/01/2002 | US20020103125 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/01/2002 | US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods |
| 08/01/2002 | US20020102723 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 08/01/2002 | US20020102721 Diagnosing cancer; obtain sample, monitor concentration tumor suppressor proteins, compare to control, amplified concentration indicate cancer |
| 08/01/2002 | US20020102711 Polypeptide for use in the treatment of cancer and immunological |
| 08/01/2002 | US20020102710 Polypeptide for use in the treatment of cancer, autoimmune diseases and inflammation |
| 08/01/2002 | US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders |
| 08/01/2002 | US20020102706 Polypeptide for use in treatment of cell proliferation disorders |
| 08/01/2002 | US20020102701 licD1 |
| 08/01/2002 | US20020102691 Enzymatic polypeptide for use in treatment and prevention of, heart liver and inflammatory disorders |
| 08/01/2002 | US20020102688 Nucleotide sequences coding polypeptide for use as anticoagulant and antiseptic |
| 08/01/2002 | US20020102687 Luciferase and photoprotein |
| 08/01/2002 | US20020102684 Human phospholipase inhibitor |
| 08/01/2002 | US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy |
| 08/01/2002 | US20020102666 PSCA: prostate stem cell antigen and uses thereof |
| 08/01/2002 | US20020102659 Cocaethylene immunogens and antibodies |
| 08/01/2002 | US20020102658 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
| 08/01/2002 | US20020102657 Binding protein for use as therapeutic tool in the prevention of Infections disease |
| 08/01/2002 | US20020102653 DNA coding for human cell surface antigen |
| 08/01/2002 | US20020102651 Novel B7-4 molecules and uses therefor |
| 08/01/2002 | US20020102649 Human transport protein homologs |
| 08/01/2002 | US20020102647 Nucleotide sequences coding membrane protein for use in treatment of nervous system disorders and arthritis |
| 08/01/2002 | US20020102645 Novel member of the lysyl oxidase gene family |
| 08/01/2002 | US20020102643 Dorsal tissue affecting factor and compositions |
| 08/01/2002 | US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging |
| 08/01/2002 | US20020102640 Nucleotide sequences coding preferential protein for use in the diagnosis, prevention and treatment of cancer |
| 08/01/2002 | US20020102622 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 08/01/2002 | US20020102620 Immunoglobulins for use in the diagnosis and detection parasites |
| 08/01/2002 | US20020102619 Heparanase specific molecular probes and their use in research and medical applications |
| 08/01/2002 | US20020102614 Detecting muscular disorder in humans; obtain sample tissue, measure zinc finger proteins, compare to control, evaluate for muscular disorder |
| 08/01/2002 | US20020102613 Novel Fab fragment libraries and methods for their use |
| 08/01/2002 | US20020102609 Antagonists of HMG1 for treating inflammatory conditions |
| 08/01/2002 | US20020102604 Full-length human cDNAs encoding potentially secreted proteins |
| 08/01/2002 | US20020102603 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 08/01/2002 | US20020102585 Prostate growth-associated membrane proteins |
| 08/01/2002 | US20020102569 Nucleotide sequences for use in the detection, classificataions, treatment and evaluation of cancer therapies |
| 08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | US20020102278 Cellular vaccines and immunotherapeutics and methods for their preparation |
| 08/01/2002 | US20020102276 For diagnosis, therapy and prophylaxis of Neisseria meningitidis infection; vaccine |
| 08/01/2002 | US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 08/01/2002 | US20020102269 Contacting a parental Helicobacter with molecule in biological sample, testing and comparing response to extracellular pH and sensitivity to acidity of parental strain to a strain deficient in UreI; selecting molecule |
| 08/01/2002 | US20020102268 For use in detecting apoptosis and testing candidate compounds for enhancing or inhibiting apoptosis |
| 08/01/2002 | US20020102264 Uses of monoclonal antibody 8H9 |
| 08/01/2002 | US20020102263 Diagnosis and treatment of malignant neoplasms |
| 08/01/2002 | US20020102262 For prophhylaxis of Staphylococcus aureus infection |